You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letters
Biliary tract cancer in male printers and typesetters in the European rare cancer case-control study
  1. Wolfgang Ahrens1,2,
  2. Franco Merletti3,
  3. Dario Mirabelli3
  1. 1 Department of Epidemiological Methods and Etiologic Research, Leibniz Institute for Prevention Research and Epidemiology—BIPS, Bremen, Germany
  2. 2 Faculty of Mathematics and Computer Science, Institute for Statistics, University of Bremen, Bremen, Germany
  3. 3 Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin and Città della Scienza e della Salute Hospital, Turin, Italy
  1. Correspondence to Professor Franco Merletti, Epidemiologia dei Tumori, via Santena 7, Torino 10126, Italy; franco.merletti{at}unito.it

https://doi.org/10.1136/oemed-2014-102322

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Kumagai et al recently observed a striking increase in mortality from cholangiocarcinoma (CC) among workers in a colour proof-printing shop in Japan, based on six deaths among 11 CC cases in a group of 62 workers employed between 1991 and 2006. Exposure to 1,2-dichloropropane and dichloromethane was reported.1 Kubo et al extended the observation including 111 workers employed from 1981 to 2012, and reported 17 CC cases.2

    The Nordic Occupational Cancer Study (NOCCA) was used to explore the generalisability of the Japanese cluster findings to the printing industry and related occupations at large.3 An overall standardised incidence ratio (SIR) of 2.34 (95% CI 95% CI 1.45 to 3.57) was found for intrahepatic CC, based on 21 cases in men. Women had an SIR of 1.95 (95% CI 0.84 to 3.85) with …

    View Full Text

    Footnotes

    • Contributors WA conducted the analyses, all authors designed the study, assessed results and wrote the letter.

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval Multicentric study: all participating countries and centres obtained approval by the appropriate independent ethical Committee.

    • Provenance and peer review Not commissioned; internally peer reviewed.